Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy

The systemic immune‐inflammation index (SII = N × P/L) based on neutrophil (N), platelet (P) and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours and can fully reflect the balance between host inflammatory and immune status. This study is conducted to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Kong, Xiangyi, Wang, Zhongzhao, Wang, Xiangyu, Fang, Yi, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077539/
https://www.ncbi.nlm.nih.gov/pubmed/31989747
http://dx.doi.org/10.1111/jcmm.14934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077539/
https://www.ncbi.nlm.nih.gov/pubmed/31989747
http://dx.doi.org/10.1111/jcmm.14934

Ejemplares similares